Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Scientists create synthetic form of SBV
Schmallenberg study raises vaccine hopes

Scottish scientists have made a synthetic version of the Schmallenberg virus (SBV) in the laboratory, raising hopes for the development of a vaccine for the disease.

The synthetic version was formed so that scientists were able to study its genetics and how it infects farm animals. They manipulated the virus's genetic sequence so it was more and less severe during the study.

Experiments showed that, if the virus is passed to calves or lambs during pregnancy, it replicates itself in the brain cells and spinal cords of the unborn animals.

Massimo Palmarini and Alan Kohl led the study at the MRC-University of Glasgow Centre for Virus Research.

Professor Palmarini said: "This is the first time we have been able to manipulate the genome of SBV in this way. We now know much more about how the virus causes the disease than we did a couple of months ago."

SBV was first discovered in Germany in November 2011 and has since spread to the UK, via midges that were blown over from the continent. The virus is now carried by native midges, and has affected about 1,000 farms across England and Wales.

An SBV vaccine is currently undergoing tests for European approval.

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com